BPC
AUXL

Banque Pictet & Cie’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Banque Pictet & Cie’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,560
Closed -$272K – 504
2014
Q2 		$272K Hold
13,560
– – 0.01% 384
2014
Q1 		$369K Buy
+13,560
New +$360K 0.01% 302

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Banque Pictet & Cie's AUXL Position: Q3 2014 in Review

Banque Pictet & Cie sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 13,560 shares — an estimated $272K sold.

Banque Pictet & Cie first reported a position in AUXL in Q1 2014 and held it in 2 quarters. The position peaked at $369K in Q1 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Banque Pictet & Cie reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 13,560 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $272K.
  • Banque Pictet & Cie first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 2 quarters.
  • Banque Pictet & Cie's AUXILIUM PHARAMCEUTICALS INC position peaked at $369K in Q1 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Banque Pictet & Cie's 13F filing for Q3 2014, filed 7 Nov 2014.